Literature DB >> 21779143

MOLECULAR BASIS OF HEREDITARY COLORECTAL CANCER.

Matthew R Hughes1, Emina H Huang.   

Abstract

Advances in molecular biology have defined the molecular basis for colorectal cancer (CRC). Though only a fraction of CRC has been determined to have a hereditary component, the discovery of genetic alterations in these clinical syndromes has permitted definition of similar discoveries in sporadic CRC. Here we will delineate the molecular basis for the most common of these defined syndromes, including familial adenomatous polyposis, hereditary non-polyposis colon cancer, MUTYH associated polyposis, Juvenile polyposis, Peutz-Jeghers syndrome, and Cowden's syndrome. The newest paradigm with implications for the pathogenesis of sporadic CRC is called the cancer stem cell hypothesis. As this paradigm also implicates aberrations in molecular pathways, a brief discussion of this hypothesis is included.

Entities:  

Year:  2011        PMID: 21779143      PMCID: PMC3138675          DOI: 10.1053/j.scrs.2010.12.002

Source DB:  PubMed          Journal:  Semin Colon Rectal Surg        ISSN: 1043-1489


  38 in total

Review 1.  The KRAS oncogene: past, present, and future.

Authors:  Onno Kranenburg
Journal:  Biochim Biophys Acta       Date:  2005-10-25

Review 2.  Gardner syndrome: skin manifestations, differential diagnosis and management.

Authors:  Edward Juhn; Amor Khachemoune
Journal:  Am J Clin Dermatol       Date:  2010       Impact factor: 7.403

3.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

4.  p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis.

Authors:  S J Baker; A C Preisinger; J M Jessup; C Paraskeva; S Markowitz; J K Willson; S Hamilton; B Vogelstein
Journal:  Cancer Res       Date:  1990-12-01       Impact factor: 12.701

Review 5.  Molecular genetics and clinical-pathology features of hereditary nonpolyposis colorectal carcinoma (Lynch syndrome): historical journey from pedigree anecdote to molecular genetic confirmation.

Authors:  H T Lynch; T Smyrk; J F Lynch
Journal:  Oncology       Date:  1998 Mar-Apr       Impact factor: 2.935

Review 6.  MutS homologs in mammalian cells.

Authors:  R Fishel; T Wilson
Journal:  Curr Opin Genet Dev       Date:  1997-02       Impact factor: 5.578

7.  APC mutations occur early during colorectal tumorigenesis.

Authors:  S M Powell; N Zilz; Y Beazer-Barclay; T M Bryan; S R Hamilton; S N Thibodeau; B Vogelstein; K W Kinzler
Journal:  Nature       Date:  1992-09-17       Impact factor: 49.962

8.  Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis.

Authors:  Emina H Huang; Mark J Hynes; Tao Zhang; Christophe Ginestier; Gabriela Dontu; Henry Appelman; Jeremy Z Fields; Max S Wicha; Bruce M Boman
Journal:  Cancer Res       Date:  2009-03-31       Impact factor: 12.701

9.  Phenotypic characterization of human colorectal cancer stem cells.

Authors:  Piero Dalerba; Scott J Dylla; In-Kyung Park; Rui Liu; Xinhao Wang; Robert W Cho; Timothy Hoey; Austin Gurney; Emina H Huang; Diane M Simeone; Andrew A Shelton; Giorgio Parmiani; Chiara Castelli; Michael F Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-04       Impact factor: 11.205

10.  Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy.

Authors:  Scott J Dylla; Lucia Beviglia; In-Kyung Park; Cecile Chartier; Janak Raval; Lucy Ngan; Kellie Pickell; Jorge Aguilar; Sasha Lazetic; Stephanie Smith-Berdan; Michael F Clarke; Tim Hoey; John Lewicki; Austin L Gurney
Journal:  PLoS One       Date:  2008-06-18       Impact factor: 3.240

View more
  1 in total

1.  The common variant rs4444235 near BMP4 confers genetic susceptibility of colorectal cancer: an updated meta-analysis based on a comprehensive statistical strategy.

Authors:  Li Liu; Qinji Su; Lixia Li; Xiaohui Lin; Yu Gan; Sidong Chen
Journal:  PLoS One       Date:  2014-06-16       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.